171 related articles for article (PubMed ID: 33651317)
21. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
22. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.
Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A
World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070
[TBL] [Abstract][Full Text] [Related]
23. Limited role of carbidopa-assisted
Imperiale A; Averous G; Helali M; Taieb D; Pessaux P; Goichot B; Addeo P; Bachellier P
Ann Nucl Med; 2019 Sep; 33(9):697-707. PubMed ID: 31214959
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.
Zhang P; Li Z; Li J; Li J; Zhang X; Lu Z; Sun Y; Li Y; Zhou J; Wang X; Peng Z; Shen L; Lu M
Cancer Med; 2021 Jul; 10(14):4855-4863. PubMed ID: 34109756
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
[TBL] [Abstract][Full Text] [Related]
26. Duodenal carcinoid tumors: how aggressive should we be?
Zyromski NJ; Kendrick ML; Nagorney DM; Grant CS; Donohue JH; Farnell MB; Thompson GB; Farley DR; Sarr MG
J Gastrointest Surg; 2001; 5(6):588-93. PubMed ID: 12086896
[TBL] [Abstract][Full Text] [Related]
27. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
[TBL] [Abstract][Full Text] [Related]
28. [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy].
Fischer L; Mehrabi A; Büchler MW
Chirurg; 2011 Jul; 82(7):583-90. PubMed ID: 21656305
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
30. Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study.
Lee SW; Sung JK; Cho YS; Bang KB; Kang SH; Kim KB; Kim SH; Moon HS; Song KH; Kim SM; Chung IK; Lee DS; Jeong HY; Youn SJ
Medicine (Baltimore); 2019 Jun; 98(26):e16154. PubMed ID: 31261543
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of endoscopic submucosal dissection for upper gastrointestinal submucosal tumors treatment and value of endoscopic ultrasonography in pre-operation assess and post-operation follow-up: a prospective study of 224 cases in a single medical center.
He G; Wang J; Chen B; Xing X; Wang J; Chen J; He Y; Cui Y; Chen M
Surg Endosc; 2016 Oct; 30(10):4206-13. PubMed ID: 26823060
[TBL] [Abstract][Full Text] [Related]
33. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
[TBL] [Abstract][Full Text] [Related]
34. Use of Preoperative MRI to Select Candidates for Local Excision of MRI-Staged T1 and T2 Rectal Cancer: Can MRI Select Patients With N0 Tumors?
An C; Huh H; Han KH; Kim MJ; Kim NK; Kim H; Lim JS
Dis Colon Rectum; 2015 Oct; 58(10):923-30. PubMed ID: 26347963
[TBL] [Abstract][Full Text] [Related]
35. [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].
Liersch T; Langer C; Jakob C; Müller D; Ghadimi BM; Siemer A; Markus PM; Füzesi L; Becker H
Chirurg; 2003 Mar; 74(3):224-34. PubMed ID: 12647079
[TBL] [Abstract][Full Text] [Related]
36. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
[TBL] [Abstract][Full Text] [Related]
37. [Surgical approach of gastroduodenal neuroendocrine neoplasms].
Fendrich V; Bartsch DK
Chirurg; 2016 Apr; 87(4):280-7. PubMed ID: 26779647
[TBL] [Abstract][Full Text] [Related]
38. Major and Minor Duodenal Papilla Neuroendocrine Tumors in Type 1 Neurofibromatosis: Case Report.
Zandomeni MR; Chahdi Beltrame M; de Santibañes M; Mazza O; Pekolj J; de Santibañes E; Sanchez Claria R
J Gastrointest Cancer; 2018 Mar; 49(1):71-74. PubMed ID: 27374033
[No Abstract] [Full Text] [Related]
39. A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.
Kachare SD; Liner KR; Vohra NA; Zervos EE; Fitzgerald TL
Am Surg; 2014 Aug; 80(8):821-6. PubMed ID: 25105406
[TBL] [Abstract][Full Text] [Related]
40. Surgical procedure depending on the depth of tumor invasion in duodenal cancer.
Kato Y; Takahashi S; Kinoshita T; Shibasaki H; Gotohda N; Konishi M
Jpn J Clin Oncol; 2014 Mar; 44(3):224-31. PubMed ID: 24470586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
